COMPANY INFO
Aiberry, founded in 2019, is a private company headquartered in Bellevue, Washington, specializing in mental health and outpatient clinical services. The company was co-founded by Linda Chung, Johan Bjorklund, Lior Auslander, and Newton Howard, and employs around 15-17 people. Aiberry develops an AI-powered mental health screening platform that analyzes speech, facial expressions, and audio-visual features during short conversations to provide real-time risk scores and health insights, enabling healthcare providers to improve early detection and treatment outcomes for mental health disorders.
Aiberry Inc., founded in 2019, is a private company based in Bellevue, Washington, operating in the Clinics/Outpatient Services industry. With a team of around 17 employees, Aiberry specializes in developing AI-powered mental health screening tools that analyze speech, facial expressions, and audio-visual cues during short conversations. These tools provide real-time risk scores and actionable health insights, supporting healthcare providers in early detection and improved treatment outcomes for mental health disorders.
Aiberry Inc. has demonstrated a strong funding trajectory, raising approximately $10.85 million over four funding rounds. The company’s fundraising strategy includes a blend of seed and mezzanine rounds, emphasizing both foundational product development and subsequent phases of growth and market expansion. Notable funding milestones include sizeable seed rounds to jumpstart initial development and a recent mezzanine round to fuel revenue generation and business scaling. Throughout its funding journey, Aiberry Inc. has attracted interest from reputed venture capital groups and strategic investors.
This mezzanine round was aimed at supporting revenue generation and market expansion as Aiberry Inc. prepared to scale its business operations further.
The funds from this seed round were used to accelerate company growth, invest in scaling up operations, and support broader market entry initiatives.
Aiberry Inc. utilized this seed funding to continue product development and support early market activities as the company gained traction.
This major seed round, led by Confluence Capital Group, provided the foundation for initial product development and launch of Aiberry Inc.’s AI-powered mental health screening platform.
Confluence Capital Group has played a pivotal role as a lead investor, particularly driving the substantial seed round in March 2023. Their involvement has provided financial stability and strategic guidance during Aiberry Inc.’s early-stage product development and scaling initiatives.
GranCorp Holdings participated in the mezzanine round, supporting Aiberry funding efforts for business scaling and revenue generation. Their investment reflects confidence in the company’s growth prospects and expanding market presence.
Ascension AI joined as an investor in the mezzanine round, enhancing Aiberry Inc. investors’ network and contributing expertise relevant to AI-driven healthcare solutions. Their support has further solidified Aiberry’s innovation and expansion strategies.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Aiberry Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.